CEST cardiac MRI enabled noninvasive estimation of myocardial phosphocreatine concentration, detecting a decrease from 13.2 mM at rest to 7.1 mM during exercise in humans (p<0.001).
Observational (n=22)
Does CEST-CMR accurately quantify myocardial phosphocreatine concentration compared to ³¹P-MRS under physiological and pharmacological stress?
CEST-CMR is a feasible, noninvasive method for estimating myocardial phosphocreatine concentration in vivo and detecting physiologic energetic changes during stress, with results consistent with ³¹P-MRS.
Absolute Event Rate: 7.1% vs 7.7%
p-value: p=<0.001
Phosphocreatine (PCr) exhibits a distinct chemical exchange saturation transfer (CEST) resonance at ~2.5 ppm with slower exchange kinetics and lower pH sensitivity than creatine. This pilot study evaluated the feasibility of quantifying myocardial PCr-dominated concentration (PCr d ) using CEST cardiac MRI (CEST-CMR) and validated the measurements with phosphorus magnetic resonance spectroscopy (³¹P-MRS). Phantoms with varied concentrations of PCr and Cr were scanned to characterize PCr CEST signals under physiological conditions. Experiments were conducted at both room temperature and 37 °C with full Z-spectra acquisition. For the study in vivo , CEST imaging was performed in normal canines (n = 13), at rest and after regadenoson vasodilation, and during dobutamine stress (n=5). In addition, healthy volunteers (n =9) underwent rest–exercise–recovery studies with in-magnet plantar-flexion exercise. Both CEST images and ³¹P-MRS were acquired in separate exercise sessions. WASSR-derived corrected The Z-spectra corrected by derived B₀ maps were fitted with a three-pool Bloch–McConnell model (water, PCr, magnetization transfer) to estimate PCr d . For ³¹P-MRS, PCr/γATP ratios were converted to PCr concentrations using γATP as a reference. Rate-pressure product (RPP) was used as an indicator of myocardial oxygen consumption. In phantoms, PCr-dominated CEST contrast increased monotonically with PCr concentration across pure and mixed PCr/Cr solutions, while Cr-only phantoms did not produce artifactual PCr estimates. In canines, myocardial PCr d was 12.0 ± 1.8 mM at rest and decreased to 7.1 ± 1.6 mM during dobutamine stress (p<0.001), while remaining unchanged with regadenoson vasodilation (11.8 ± 0.3 vs 11.8 ± 0.6 mM). Changes in PCr d correlate d negatively with RPP (r = −0.75). In human subjects, CEST-derived PCr d was 13.2 ± 1.4 mM at rest, 7.1 ± 1.0 mM during exercise (p<0.001), and 12.9 ± 1.5 mM during hyperemia. Corresponding ³¹P-MRS estimates were 12.9 ± 1.4 mM, 7.7 ± 2.3 mM, and 12.2 ± 1.6 mM, respectively. CEST-derived PCr d showed a moderate negative correlation with RPP (r = −0.52). CEST-CMR enables noninvasive estimation of myocardial PCr d in vivo and detects physiologic energetic changes during stress, with measurements consistent with ³¹P-MRS.
Huang et al. (Wed,) conducted a observational in Healthy (n=22). CEST cardiac MRI (CEST-CMR) vs. Phosphorus magnetic resonance spectroscopy (31P-MRS) was evaluated on Myocardial PCr-dominated concentration ([PCr]d) during exercise in human subjects (p=<0.001). CEST cardiac MRI enabled noninvasive estimation of myocardial phosphocreatine concentration, detecting a decrease from 13.2 mM at rest to 7.1 mM during exercise in humans (p<0.001).